Steve Pakola, Chief Medical Officer at REGENXBIO Inc. (RGNX), sold 5,124 shares at $10.35 ($53K) on 2026-03-10, disclosed to the SEC on 2026-03-12.
Open-market sale of $53k RGNX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RGNX | SELL | 2026-05-13 | $169K | — | Filing → |
| RGNX | SELL | 2024-03-07 | $730K | — | Filing → |
| RGNX | SELL | 2024-01-04 | $600K | — | Filing → |